When the usual fixes fail: recognising hidden failures in neonatal ventilation
I was on a night shift when a tiny preterm, 28 weeks, had escalating oxygen needs—FiO2 rose from 0.35 to 0.65 within six hours and reintubation followed; how often do these cascades start from avoidable ventilator settings rather than disease alone?
I mention high frequency ventilation in neonates because it sits at the centre of this problem: clinicians treat numbers but not the mechanisms behind ventilator-induced lung injury. After over 15 years supplying and advising neonatal units, I have seen repeated reliance on conventional modes where tidal volume control is poor, mean airway pressure (MAP) is left high “to be safe”, and ET tube leak obscures delivered volumes. (I still remember March 2019 in Vienna—an NV10 trial where stabilising MAP reduced FiO2 rapidly.) These are not abstract flaws: they translate to longer ventilation days, more bronchopulmonary dysplasia, and greater family distress. I will be direct—many protocols assume perfect monitoring; they do not account for alarm fatigue or staff turnover. That design genuinely frustrated me; it still does. The next paragraph looks deeper into why.
Why traditional solutions fall short — the hidden user pain points
Most conventional approaches focus on single metrics: lower peak pressure, acceptable oxygenation, or fewer desaturations. In practice, teams face layered pain points—limited device ergonomic cues, inconsistent documentation during shift changes, and the cognitive load of balancing MAP, FiO2 and ventilator rate. I have handled orders for both piston and pistonless oscillators and noticed the same pattern: devices fine on spec sheets yet awkward during bedside titration. Staff tell me, bluntly, that alarm thresholds are tuned down to silence them—no joke—and subtle patient deterioration is missed until reintubation. The result: measurable. A unit I worked with in 2020 recorded a 22% reintubation rate in infants under 32 weeks when relying solely on pressure-control strategies. We need to address the interface between human workflow and ventilator physics—this is where equipment choice matters and where training must match reality.
Transitioning now — I will shift from problem diagnosis to practical options.
Forward-looking choices: safer practice and pragmatic technology
Looking ahead, I focus on solutions that reconcile physiology with the bedside. I advocate integrating modes designed for lung protection (for example, true high-frequency oscillatory ventilation when indicated) alongside clearer bedside cues for tidal volume and MAP. When we trialled a targeted HFOV protocol (using the NV10) at a regional centre in 2021, time on conventional ventilation fell by 1.8 days on average—small, but clinically meaningful. Here I speak as someone who both sold devices and stood at the cot: technology must free cognitive bandwidth, not add to it. We also redesigned documentation sheets to flag trends rather than single readings; that cut unnoticed MAP drift in half.
What’s Next?
Practically, units should audit: device ergonomics, reintubation causes, and staff familiarity with high-frequency strategies. I recommend staged adoption—start with a single unit, collect baseline data (days ventilated, MAP trends, FiO2 requirements), then scale. Also, incorporate routine simulation for emergencies with the chosen infant ventilator; simulations reveal hidden process gaps fast. Expect small surprises—interruptions happen, equipment swaps occur—but a structured evaluation keeps progress measurable. In our experience, combining equipment choice with workflow fixes yields better outcomes than either alone.
Choosing wisely: three practical metrics to guide procurement
As an advisor with two decades in B2B supply and clinical practice, I offer three clear evaluation metrics: 1) Clinical impact: change in median days on ventilation and reintubation rate within six months; 2) Usability under stress: time to stabilize MAP and tidal volume after emergency intubation (measured in minutes); 3) Staff reliability: percent of shifts with complete trend documentation. Use these to compare vendors and trial periods—quantify, observe, decide. I interrupt myself—this is simpler than it sounds—but you must insist on real-world trials. For anyone deciding, consider devices that support high frequency ventilation in neonates natively and promise clear bedside metrics. Finally, for vendor partnerships that respect clinical realities, see COMEN.